| Bioactivity | Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer[1]. |
| Invitro | Timigutuzumab 经过糖优化，可增强抗体依赖性细胞介导的细胞毒性[1]。 |
| Name | Timigutuzumab |
| CAS | 1665274-14-5 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Santis RD. Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy. MAbs. 2020 Jan-Dec;12(1):1725346. |